Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dunlop

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Genomics|May 8, 1998
Organization of the human glucokinase regulator gene GCKRB E Hayward, N Dunlop, S Intody, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 18, 2015
Economic evaluation in chronic pain: a systematic review and de novo flexible economic modelW Sullivan, M Hirst, S Beard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivityC F Barbas, D Hu, N Dunlop, et al.
Biochemical Society Transactions|February 1, 1997
Molecular genetics of the human glucokinase regulator-fructokinase (GCKR-KHK) region of chromosome 2p23B E Hayward, J P Warner, N Dunlop, et al.
Journal of Virology|August 1, 1990
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzeesP L Nara, L Smit, N Dunlop, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1992
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitroC F Barbas, E Björling, F Chiodi, et al.
Science (New York, N.Y.)|November 11, 1994
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibodyD R Burton, J Pyati, R Koduri, et al.
Journal of Virology|January 1, 1992
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboonsN L Haigwood, P L Nara, E Brooks, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Genomics|May 8, 1998
Organization of the human glucokinase regulator gene GCKRB E Hayward, N Dunlop, S Intody, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 18, 2015
Economic evaluation in chronic pain: a systematic review and de novo flexible economic modelW Sullivan, M Hirst, S Beard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivityC F Barbas, D Hu, N Dunlop, et al.
Biochemical Society Transactions|February 1, 1997
Molecular genetics of the human glucokinase regulator-fructokinase (GCKR-KHK) region of chromosome 2p23B E Hayward, J P Warner, N Dunlop, et al.
Journal of Virology|August 1, 1990
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzeesP L Nara, L Smit, N Dunlop, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1992
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitroC F Barbas, E Björling, F Chiodi, et al.
Science (New York, N.Y.)|November 11, 1994
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibodyD R Burton, J Pyati, R Koduri, et al.
Journal of Virology|January 1, 1992
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboonsN L Haigwood, P L Nara, E Brooks, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
Pageof 4